Hyperthyroidism has been reported to affect all of the major determinants of left ventricular performance in a manner that would augment ventricular shortening characteristics. The hypothesis tested in this study is that reduced afterload in conjunction with increased preload and heart rate, rather than augmented contractility, ac• counts for much of the increase in left ventricular per• formance noted previously in these patients. To inves• tigate this hypothesis, 11 hyperthyroid patients were evaluated serially over 4 ± 2 months. With therapy, serum total thyroxin (T 4) decreased significantly (p < 0.001). Ventricular hemodynamics were assessed by two• dimensionlll targeted M-mode echocardiograms and cal• ibrated carotid pulse tracings. Ventricular preload was estimated by end-diastolic dimension, whereas afterload was measured as end-systolic wall stress. Overall left ventricular performance was quantitated by the extent and velocity of shortening, whereas myocardial work was assessed by ventricular systolic stress-length rela• tiohs.
Myocardial Mechanics in

Chicago. lllinois
Hyperthyroidism has been reported to affect all of the major determinants of left ventricular performance in a manner that would augment ventricular shortening characteristics. The hypothesis tested in this study is that reduced afterload in conjunction with increased preload and heart rate, rather than augmented contractility, ac• counts for much of the increase in left ventricular per• formance noted previously in these patients. To inves• tigate this hypothesis, 11 hyperthyroid patients were evaluated serially over 4 ± 2 months. With therapy, serum total thyroxin (T 4) decreased significantly (p < 0.001). Ventricular hemodynamics were assessed by two• dimensionlll targeted M-mode echocardiograms and cal• ibrated carotid pulse tracings. Ventricular preload was estimated by end-diastolic dimension, whereas afterload was measured as end-systolic wall stress. Overall left ventricular performance was quantitated by the extent and velocity of shortening, whereas myocardial work was assessed by ventricular systolic stress-length rela• tiohs.
Overall left ventricular performance reflects the net inter• action of preload, afterload, heart rate and contractility. It is generally believed that hyperthyroidism affects all of these factors in a manner that enhances ventricular shortening characteristics (1) (2) (3) (4) (5) (6) (7) . This is based on the fact that total plasma volume (8) (and presumably ventricular preload), heart rate and contractility are augmented whereas afterload (as measured by systemic vascular resistance) is reduced (5, 7) . Previous clinical studies of hyperthyroidism have used traditional ejection phase indexes (for example. ejection latter finding has been shown previously to have no sig• nificant effect on left ventricular contractile state over the range of heart rates encountered in this study. In all cases, the end-systolic stress/rate-corrected shortening velocity relation fell with attainment of normal thyroid status, characteristic of a decline in contractility. There was a strong positive correlation between left ventricular contractility and serum thyroid hormone level (r = 0.83).
In addition, ventricular minute work declined with ther• apy (p < 0.01). Thus, the hyperkinesia of hyperthy• roidism in humans is due to augmented contractility rather than altered loading or chronotropic conditions.
(J Am Coli CardioI1986;7:967-74) fraction, shortening fraction and systolic time intervals) to assess changes in overall left ventricular performance. Un• fortunately, these indexes are unable to separate thyroid hormone-induced alterations in ventricular contractility that have been demonstrated in isolated muscle (9,10) from changes in preload, afterload and heart rate in patients with hyperthyroidism (2, 5, 7, (11) (12) (13) . In addition, the relative contribution of each of these factors to the augmented myo• cardial mechanics in humans with hyperthyroidism has yet to be established. Recently, several noninvasively determined indexes of ventricular function have been shown to be clinically useful in the assessment of subtle abnormalities in left ventricular contractile state (14) (15) (16) . The most promising of these is the relation between left ventricular end-systolic wall stress and rate-corrected velocity of fiber shortening (15) . This index is independent of preload. incorporates afterload, heart rate and left ventricular mass and is sensitive to alterations in left ventricular contractile state (15) . range 15 to 36; normal range 6 to 10. Serum thyroxine and triiodothyronine were determined by radioimmunoassay and the free thyroxine index was calculated as the product of the serum thyroxine and a normalized resin thyroxine uptake (17) . The time interval from onset of symptoms to the first echocardiographic examination was 5 ± 3 months (range 2 to 12). Patients were excluded from the study if they 1) had known cardiovascular disease not related to hyperthy• roidism (for example, history of myocardial infarction or ventricular arrhythmia), 2) were receiving beta-adrenergic blocking agent therapy, or 3) demonstrated left ventricular regional wall motion abnormalities on screening two-di• mensional echocardiographic examination. All study pa• tients were initially treated with propylthiouracil. This was followed by subtotal thyroidectomy in five patients and treat• ment with iodine-131 in two patients. All patients had sinus rhythm throughout the study period. Results were compared with data obtained from 11 age-matched (34 ± 12 years) normal control subjects. Written informed consent was ob• tained according to a protocol approved by the Clinical Investigation Committee of The University of Chicago Hos• pitals and Clinics.
Experimental protocol. The experimental protocol has been described previously in detail (14) (15) (16) (18) . Left ventricular end-systolic and end-diastolic dimensions (Des-D ed ) and wall thicknesses (he" h ed ) were measured from the echocardiographic recordings as previ• ously described (14) (15) (16) . Left ventricular mass index (LVMI) was calculated according to a modification of the method of Devereux et al. (19) :
-13.6/body surface area.
Total systemic resistance was calculated as mean arterial pressure divided by the echocardiographically derived car• diac output and converted to dynes.cms -5 (20) . This as• sumes that the left ventricle contracts in a symmetric man• ner, a finding confirmed for each subject in our study by two-dimensional echocardiographic imaging. The left ven• tricular percent fractional shortening (%AD) was calculated as end-diastolic dimension minus end-systolic dimension divided by end-diastolic dimension. The left ventricular end• systolic pressure was estimated by linear interpolation to the height of the incisura using a calibrated carotid pulse tracing (18) . The left ventricular ejection time (LVET) was measured from the carotid pulse tracing in the standard manner (21) . The rate-corrected left ventricular mean ve• locity of fiber shortening (Vcf c ) was calculated as:
where %AD = percent change in ventricular dimension and RR = the interval between cardiac cycles as determined from the electrocardiogram (15) . Three to five cardiac cycles for each M-mode echocar• diographic recording were digitized using a Franklin Quan• tic 1200 off-line data analysis system (Bruce Franklin, Inc.). This device has a digitizing pad with a sampling rate of 80/cm (400/s). The Quantic 1200 is programmed to correct for pulse transmission time by aligning the dicrotic notch of the carotid pulse tracing with the first high frequency component of the aortic component of the second heart sound. Left ventri<::ular meridional wall stress (a) was cal• culated using the angiographically validated formula (22):
where ais in g/cm 2 ; P (pressure) is in mm Hg; D (dimension) and h (thickness) are in cm; and 1.35 is the factor to convert P e , (end-systolic pressure) from mm Hg to g/cm2, Peak systolic and end-systolic wail stresses were calculated. Mean wall stress during left ventricular ejection was calculated as the average of instantaneous wall stress values from onset to end-ejection, Stress-time and stress-dimension plots cal• culated by the Quantic 1200 were digitized. Left ventricular stress-time (g.s/cm2) and systolic stroke work indexes (g/cm per m 2 body surface area) were calculated as the integral of the instantaneous stress-time and stress-dimension plots, re• spectively, from onset to end-ejection, Both indexes were multiplied by heart rate, giving left ventricular stress-time per minute and left ventricular minute work index.
Statistical analysis. Paired t tests were performed to compare maximal pretreatment and minimal posttreatment values. An unpaired t test was used to compare normal control subjects with patients before and after therapy and the Bonferroni correction was used for these multiple com• parisons, A probability (p) value of less than 0.05 was considered statistically significant. Correlations between the serial thyroid function studies and the end-systolic indexes of left ventricular contractility were determined. The cor• relation coefficients were calculated by least squares linear regression analysis. Group data are expressed as mean val• ues ± standard deviation,
Results
Clinical course. The mean duration of follow-up was 4 ± 2 months (Fig. 1) . Serum total thyroxine (T 4 ) decreased from 21 ± 6 to 5 ± 3 /Lg/dl (p < 0.001) whereas free thyroxine index decreased from 27 ± 7 to 5 ± 3 (p < 0.001). Patients pretreated with propylthiouracil were clin• ically and biochemically euthyroid before undergoing sur• gery. All patients became euthyroid within 8 weeks of ini• tiation of treatment.
Left ventricular hemodynamics (Table 1) . Left ven• tricular hemodynamics obtained in the study patients before and after therapy were compared with values from the age• matched normal subjects. The major disparities between the control and pretreatment values reflected differences in left ventricular ejection phase indexes and heart rates. In con• trast, there were no hemodynamic differences between the control and posttreatment data. There were no significant changes in peak systolic, end-systolic, diastolic or mean aortic pressures between the groups. When pre-and post• treatment values were compared, heart rate declined by 24% from 91 ± 16 beats/min before therapy to 69 ± 13 after therapy (p < 0.0l) (Fig. 2, top) . Although left ventricular end-diastolic dimension (a measure of preload) did not change after therapy (Fig. 2, bottom) , left ventricular end-systolic dimension increased by 7% (p < 0.05). With therapy the rate-corrected ejection time increased by 6% (p < 0.05) and cardiac output fell by one-third (p < 0.05). This resulted in a 32% increase in total systemic resistance (an index of Left ventricular end-systolic stress/velocity of short• ening relation. Figure 4 compares the relation between end-systolic wall stress and rate-corrected velocity of fiber shortening for the study group with the previously published mean (± 2 SD) value for this relation generated from a normal population over a wide range of end-systolic stresses (15) . In all cases initially increased contractility declined significantly with therapy. There is no overlap of rate-cor- Oed and De' = end-dIastolic and end-systolic dimension, respectively; %aD = percent shortening fractIOn; ETc = rate-corrected ejection time; HR = heart rate; L VET = left ventncular ejection time; MSTI = wall stress-time index per minute; MWI = minute work index; P p ,' Pm and P e , = peak. mean and end-systolic pressure, respectIvely; STI = wall stress-time index; SVR = total systemic resistance; uP" U m and U e, = peak, mean and end-systolic wall stress. respectIvely; Vcf and Vcf c = shortening velocity and rate-corrected shortemng velocity, respectively. rected shortening velocity for the two groups. On an indi• vidual basis, 8 of II patients had pretreatment end-systolic stress/rate-corrected shortening velocity points that ex• ceeded the 2 standard deviation confidence limits; all points were above the mean regression line for the normal popu• lation. For any end-systolic stress/rate-corrected shortening velocity point the vertical distance to the mean regression line represents the deviation from the predicted rate-cor• rected shortening velocity at that level of end-systolic wall stress. The resultant difference (that is, actual minus pre• dicted rate-corrected shortening velocity) is an index of left ventricular contractility that is independent of ventricular heart rate and loading conditions. Each point may also be described in terms of standard deviation units from the mean regression line. The group mean for the study patients fell with therapy from a value that was greater than 2 standard deviation units above the mean regression line to just below this line.
To assess the effect of thyroid hormone on myocardial contractility, the relation between thyroid hormone levels and deviation from the mean normal end-systolic stress/rate• corrected shortening velocity regression line was determined using all of the serial studies (n = 52) obtained from the patient group (Fig. 5) . Free thyroxine index correlated strongly (r = 0.83) with contractile state over a wide range of values.
The correlation coefficient for total serum thyroxine was also highly positive (r = 0.77).
Discussion
This study used left ventricular force-shortening-velocity characteristics to define myocardial mechanics before and after therapy in patients with hyperthyroidism. The follow• ing discussion addresses the effects of preload, afterload, contractility and heart rate on overall left ventricular per• formance and myocardial oxygen requirements in these pa• tients.
Preload. In spite of the increase in total body plasma volume known to accompany hyperthyroidism (8), our sub• jects did not show a change in left ventricular end-diastolic dimension with therapy. This suggests that preload is not an important determinant of the augmented ventricular per• formance in hyperthyroidism. Furthermore, it suggests that total body plasma volume and left ventricular preload are not synonymous.
Afterload. Total systemic vascular resistance increased
as patients became euthyroid. Previous investigators have found similar changes (3, 7, 23) . Interestingly, the rise in total systemic resistance (a measure of peripheral arterial tone) in our study was not associated with changes in left ventricular afterload as measured by end-, peak or mean systolic wall stress. This means that afterload reduction is not responsible for the hyperdynamic state associated with untreated hyperthyroidism. This is an example of disparity between peripheral vascular tone and the forces acting on myocardial fibers (that is, afterload) and reflects differences between the peripheral and cardiac effects of thyroid hor• mone (24) . In this study, no change was noted in left ventricular mass. Reversible cardiac hypertrophy induced by thyroid hormone has been reported in animals, but left ventricular mass increased above the normal range has yet to be dem• onstrated in adult humans (25) (26) (27) . Changes in myocardial protein synthesis induced in animals by thyroid hormone administration have not yet been found in humans.
Contractility. There was a strong positive correlation between thyroid hormone levels and myocardial contractil• ity, measured as deviation of the end-systolic stress-rate corrected velocity of fiber shortening relation from its nor-~ mal mean regression line (Fig. 5 ). This finding is consistent with a shift in the force-velocity curve upward and to the right noted previously in isolated cat papillary muscle treated with thyroxine (9) . Because our data were acquired over a mean of 4 ± 2 months at multiple stages of therapy, they suggest that left ventricular contractile state correlates closely and in a temporal manner with the patient's biochemical thyroid hormone profile (28).
Heart rate. With antithyroid therapy, heart rate fell from 91 ± 16 to 69 ± 13 beats/min. It is important to consider how this magnitude of change in heart rate could influence left ventricular contractile state. It has been demonstrated that the positive inotropic effect of a steady state increase in cardiac frequency is less marked at physiologic than at room temperature, and in the intact ventricle than in isolated cardiac tissue (29) . Also, increases in contractility appear to be considerably smaller in intact conscious dogs than in dogs in the anesthetized state (30) . We recently examined this question in 10 normal subjects. A change in heart rate from 55 ± 6 to 86 ± 8 beats/min did not significantly alter left ventricular contractilty as measured by the end-systolic stress-rate-corrected velocity of fiber shortening relations. This finding is in agreement with other studies performed over the physiologic range for heart rate in humans (31, 32) . Thus, chronotropic factors do not appear to have contributed significantly to the increased contractility associated with hyperthyroidism.
Myocardial oxygen requirements. The hypermeta• bolic state in hyperthyroidism is accompanied by increased myocardial oxygen consumption (5, 23, 33) . In this study we used the left ventricular systolic stress-time index per minute to assess relative myocardial oxygen demands. This mea• sure, which incorporates two of the three major determinants of myocardial oxygen consumption (systolic wall stress and heart rate) has been shown previously to reflect changes in myocardial oxygen consumption (34 Methodologic considerations. It has been suggested that the left ventricular hyperkinesia in hyperthyroidism is me• diated by either catecholamine excess or enhanced cate- cholamine sensitivity. Plasma catecholamine concentrations are normal or decreased in hyperthyroid patients, and myo• cardial beta-adrenergic binding sites in animals are increased (2, 26) . Beta-receptor blockade with sotalol, an agent free of intrinsic myocardial depressant properties, abolishes the tachycardia and shortened circulation time in hyperthyroid• ism, but does not change left ventricular performance (35) . This suggests that thyroxine affects the heart independent of circulating catecholamines and the sympathetic nervous system (35) . Although we did not measure serum cate• cholamine concentrations, it does not appear that this in• formation would significantly alter the interpretation of our results. Systemic vascular resistance was estimated using non• invasive techniques. As afterload (measured as end-, peak or mean systolic stress) did not change, a difference in systemic resistance in either direction would not alter our conclusions. Echocardiographic determination of cardiac output in patients with a normal sized left ventricle in the absence of wall motion abnormalities has been shown pre• viously to be accurate (36, 37) . This is particularly true when all subjects serve as their own control in serial studies using two-dimensionally targeted M-mode echocardiographic im• aging. The direction and magnitude of change in systemic resistance with therapy in these patients are similar to those reported by other investigators (7, 25) .
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Conclusion.
The hyperdynamic appearance of the left ventricle in hyperthyroidism is due to increased contractility independent of alterations in ventricular preload, afterload and heart rate.
